A detailed history of Argyle Capital Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Argyle Capital Partners, LLC holds 13,973 shares of PFE stock, worth $369,306. This represents 0.28% of its overall portfolio holdings.

Number of Shares
13,973
Previous 12,287 13.72%
Holding current value
$369,306
Previous $311 Million 8.79%
% of portfolio
0.28%
Previous 0.27%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$21.59 - $24.84 $36,400 - $41,880
1,686 Added 13.72%
13,973 $339 Million
Q1 2025

Aug 13, 2025

SELL
$25.01 - $27.13 $44,892 - $48,698
-1,795 Reduced 12.75%
12,287 $311 Million
Q4 2024

Aug 13, 2025

BUY
$24.8 - $30.19 $349,233 - $425,135
14,082 New
14,082 $374 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Argyle Capital Partners, LLC Portfolio

Follow Argyle Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argyle Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Argyle Capital Partners, LLC with notifications on news.